No Data
No Data
Shinsun Posts February Contracted Sales of 422 Million Yuan
Shinsun Holdings (Group) (HKG:2599) said total contracted sales for February amounted to around 422 million yuan with the contracted gross floor area standing at about 31,940 square meters last month,
The total contract sales of Xiangsheng Holding Group (02599) in the first two months were about 1,011 billion yuan, a year-on-year decrease of 69.54%
According to the Zhitong Finance App, Xiangsheng Holding Group (02599) announced that in February 2024, the total contract sales volume of the vested group was approximately RMB 422 million; the contracted construction area of the vested group was approximately RMB 31,900 square meters; and the average contract price of the vested group was approximately RMB 13,205 per square meter. For the two months ended February 29, 2024, the total sales of Vested Group contracts was approximately RMB 1,011 million, a year-on-year decrease of 69.54%; the contracted construction area of the Vested Group was approximately 75,400 square meters; and the average contract sales price of Vested Group was approximately RMB 134 per square meter
Shinsun Logs 5.90 Billion Yuan in January Contracted Sales
Shinsun Holdings (Group) (HKG:2599) recorded attributable contracted sales of approximately 5.90 billion yuan in January, with an attributable gross floor area of 434,319 square meters. The property c
The total contract sales of Xiangsheng Holding Group (02599.HK) belonging to the group in January was about 5.899 billion yuan
Gelonghui, Feb. 7: Xiangsheng Holding Group (02599.HK) announced that for one month ending January 31, 2024, (i) the total contract sales volume of the Vested Group was approximately RMB 5.899 billion; (ii) the contracted construction area of the Vested Group was approximately RMB 434,319 square meters; and (iii) the average contract price of the Vested Group was approximately RMB 13,583 per square meter.
Selected Announcements | New Oriental and Yu Minhong promised to purchase a total of HK$700 million Dongfang Selected Shares; Yao Ming Joint Inc. expects adjusted net profit to increase by more than 100% last year
Saisheng Pharmaceutical: The Phase III clinical trial of Vaborem® in China completed the enrollment of all subjects; Xianruida Healthcare: The registration application for PERIDGE® was approved by the China National Drug Administration.
The total revenue of Xiangsheng Holding Group (02599.HK) in 2022 was about 19.701 billion yuan, a year-on-year decrease of about 54.9%
Gelonghui, January 31, 丨 Xiangsheng Holding Group (02599.HK) announced that the total revenue for the year ended December 31, 2022 was approximately RMB 19.701 billion, a decrease of about 54.9% over the same period last year. The relevant annual loss was approximately RMB 3,927 million, which was a loss compared to profit of approximately RMB 480 million for the same period last year. The net asset liability ratio increased from 1.5 on December 31, 2021 to 3.3 on December 31, 2022. In 2022, the epidemic was repeated in many parts of the country, the real estate market performance was weak, and confidence in real estate investment and demand was insufficient
No Data